GO:0006769 nicotinamide metabolic process: NAD+ Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006769 (nicotinamide metabolic process) describes all chemical reactions and pathways involving nicotinamide, the amide form of vitamin B3, a central precursor and product of NAD+ metabolism.
• Nicotinamide is a key node in the NAD+ salvage pathway, and its metabolism is tightly regulated because NAD+ controls energy metabolism, DNA repair, and cell survival.
• Oral nicotinamide riboside, a related vitamin B3 form, is bioavailable and can elevate NAD+ in humans and mice, linking nicotinamide metabolism to systemic metabolic and inflammatory signatures.
• Nicotinamide influences skin barrier function by increasing ceramide and stratum corneum lipid biosynthesis, demonstrating tissue-specific roles beyond redox metabolism.
• Cardiac NAD+ depletion, which involves nicotinamide metabolic processes, promotes hypertrophic cardiomyopathy and arrhythmias before bioenergetic failure, highlighting its role in heart disease.
• Phages can reconstitute NAD+ to counter bacterial immunity, showing that nicotinamide metabolism is also relevant in host-microbe interactions.
Description
Nicotinamide metabolic process (GO:0006769) encompasses the chemical reactions and pathways involving nicotinamide, also known as pyridine-3-carboxamide, the amide of nicotinic acid and a member of the B complex of vitamins. This process is fundamental to cellular bioenergetics because nicotinamide is a direct precursor and product of NAD+, a coenzyme central to redox reactions, ADP-ribosylation, and sirtuin-mediated deacetylation. Researchers study this term to understand how cells maintain NAD+ pools, respond to metabolic stress, and regulate aging, inflammation, and tissue repair. The importance of nicotinamide metabolism extends from basic biochemistry to clinical translation. Nicotinamide riboside, a related vitamer, is orally bioavailable and augments NAD+ metabolome in aged human skeletal muscle, inducing transcriptomic and anti-inflammatory signatures. In the skin, nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, improving epidermal permeability barrier function. In the heart, NAD+ depletion driven by altered nicotinamide metabolism promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics. Even in microbial systems, phages reconstitute NAD+ to counter bacterial immunity, underscoring the evolutionary breadth of this pathway. Given its central role in health and disease, GO:0006769 is a high-priority target for functional genomics. Understanding which genes regulate nicotinamide metabolism, how they are controlled, and how they contribute to pathology enables the development of targeted therapies and robust experimental models.
nicotinamide metabolic process At A Glance
| GO ID | GO:0006769 |
|---|---|
| GO term | nicotinamide metabolic process |
| Ontology | biological_process |
| Synonym | niacin metabolic process; niacin metabolism; nicotinamide metabolism; vitamin B3 metabolic process; vitamin B3 metabolism |
| Major function | Maintenance of NAD+ homeostasis through salvage, synthesis, and degradation of nicotinamide |
| Key enzymes | NAMPT, NNMT, NADSYN1, NMNAT1-3, CD38, PARPs, SIRTs |
| Cellular location | Cytosol, nucleus, mitochondria, extracellular space |
| Related pathways | NAD+ salvage, de novo NAD+ biosynthesis, redox metabolism, sirtuin signaling |
| Disease relevance | Cardiomyopathy, skin barrier dysfunction, metabolic disorders, inflammation, cancer |
What Is GO:0006769?
In our own words, GO:0006769 (nicotinamide metabolic process) refers to the collection of biochemical reactions and pathways that synthesize, interconvert, or degrade nicotinamide (pyridine-3-carboxamide), a water-soluble vitamin B3 vitamer. This includes the salvage of nicotinamide to NAD+, its release from NAD+ by NAD+-consuming enzymes, and its conversion to other pyridine derivatives. The process is essential for maintaining cellular NAD+ levels and is conserved across living organisms.
Why Is nicotinamide metabolic process Important in Cell Biology?
Nicotinamide metabolic process is critically important because it governs the availability of NAD+, a coenzyme required for hundreds of redox reactions and signaling events. Dysregulation of this process is linked to aging, metabolic syndrome, cardiovascular disease, and skin disorders. Moreover, pharmacological modulation of nicotinamide metabolism, such as with nicotinamide riboside, has shown promise in augmenting NAD+ levels and improving physiological function in humans and animal models.
• Maintains cellular NAD+ pools essential for energy metabolism and mitochondrial function.
• Regulates sirtuin and PARP activities, influencing DNA repair, epigenetics, and stress responses.
• Modulates inflammation and immune responses, as shown by anti-inflammatory signatures after nicotinamide riboside supplementation.
• Supports skin barrier integrity by promoting ceramide and lipid synthesis.
• Plays a role in cardiac health; NAD+ depletion causes hypertrophic cardiomyopathy and arrhythmias.
• Involved in host-microbe interactions, including phage defense mechanisms.
• Provides targets for therapeutic intervention in metabolic and age-related diseases.
• Serves as a biomarker for NAD+ status in aging and disease.
• Impacts oral bioavailability and pharmacokinetics of vitamin B3 vitamers.
• Connects to cancer biology through NAD+ dependency of tumor cells.
What Happens During nicotinamide metabolic process?
Nicotinamide salvage to NAD+
In simple terms: Cells recycle nicotinamide back into NAD+ to keep energy production and signaling running.
The salvage pathway begins with nicotinamide phosphoribosyltransferase (NAMPT), which converts nicotinamide to nicotinamide mononucleotide (NMN). NMN is then adenylylated by nicotinamide mononucleotide adenylyltransferases (NMNAT1-3) to form NAD+. This pathway is essential for maintaining NAD+ levels in mammalian cells and is tightly regulated.
NAD+ consumption and nicotinamide release
In simple terms: Enzymes that use NAD+ break it down and release nicotinamide, which can be recycled.
NAD+-consuming enzymes such as CD38, PARPs, and sirtuins cleave NAD+ and generate nicotinamide as a byproduct. This nicotinamide can be salvaged back to NAD+ or methylated for excretion. The balance between consumption and salvage determines cellular NAD+ availability.
Nicotinamide methylation and excretion
In simple terms: Excess nicotinamide is modified for removal from the body.
Nicotinamide N-methyltransferase (NNMT) methylates nicotinamide to 1-methylnicotinamide (1-MNA), which is further oxidized and excreted. This pathway regulates nicotinamide levels and impacts methylation potential, linking nicotinamide metabolism to epigenetic regulation.
De novo synthesis and interconversion
In simple terms: Cells can also make NAD+ from other vitamin B3 forms, not just recycle nicotinamide.
Nicotinic acid and nicotinamide riboside can enter the NAD+ pool through distinct routes. Nicotinic acid is converted to nicotinic acid mononucleotide by NAPRT, while nicotinamide riboside is phosphorylated by NRKs. These pathways ensure flexibility in NAD+ biosynthesis and are targets for nutritional and pharmacological interventions.
Tissue-specific roles of nicotinamide metabolism
In simple terms: Different organs use nicotinamide metabolism for specialized functions.
In the skin, nicotinamide increases ceramide and stratum corneum lipid synthesis, improving barrier function. In the heart, NAD+ depletion due to impaired nicotinamide metabolism leads to hypertrophic cardiomyopathy and arrhythmias. In skeletal muscle, nicotinamide riboside supplementation alters the NAD+ metabolome and induces anti-inflammatory signatures.
Key Genes Involved in GO:0006769 nicotinamide metabolic process
The following genes encode enzymes and regulators that directly participate in or control nicotinamide metabolic process (GO:0006769).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NAMPT | Rate-limiting enzyme in NAD+ salvage from nicotinamide | Target for boosting NAD+ in aging and metabolic disease |
| NMNAT1 | Nuclear NMN adenylyltransferase | Mutations cause retinal degeneration; key for nuclear NAD+ |
| NMNAT2 | Cytoplasmic NMN adenylyltransferase | Essential for axon survival; linked to neurodegeneration |
| NMNAT3 | Mitochondrial NMN adenylyltransferase | Regulates mitochondrial NAD+ and metabolism |
| NNMT | Methylates nicotinamide to 1-MNA | Modulates NAD+ levels and methylation; implicated in cancer and obesity |
| CD38 | NAD+ glycohydrolase releasing nicotinamide | Major NAD+ consumer; target for NAD+ restoration |
| PARP1 | NAD+-dependent DNA repair enzyme | Consumes NAD+ and releases nicotinamide; linked to cancer and aging |
| SIRT1 | NAD+-dependent deacetylase | Regulates metabolism, inflammation, and aging |
| SIRT3 | Mitochondrial NAD+-dependent deacetylase | Controls mitochondrial function and ROS |
| NADSYN1 | Glutamine-dependent NAD+ synthetase | Final step of de novo NAD+ synthesis |
| NAPRT | Nicotinic acid phosphoribosyltransferase | Preiss-Handler pathway for NAD+ from nicotinic acid |
| NRK1 | Nicotinamide riboside kinase 1 | Phosphorylates nicotinamide riboside for NAD+ salvage |
| NRK2 | Nicotinamide riboside kinase 2 | Muscle-specific NRK; involved in NR metabolism |
| QPRT | Quinolinate phosphoribosyltransferase | De novo NAD+ synthesis from tryptophan |
| ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Regulates de novo NAD+ pathway flux |
| SLC22A13 | Nicotinate transporter | Uptake of nicotinic acid and related vitamers |
| SLC5A8 | Sodium-coupled monocarboxylate transporter | Transports nicotinate and butyrate |
How Is nicotinamide metabolic process Regulated?
Nicotinamide metabolic process is regulated at multiple levels. The salvage enzyme NAMPT is controlled by circadian rhythms, metabolic status, and inflammatory signals, ensuring NAD+ levels fluctuate with feeding and fasting. NNMT expression is regulated by stress and hormonal cues, affecting nicotinamide methylation and excretion. NAD+-consuming enzymes such as CD38 and PARPs are activated by immune and DNA damage signals, increasing nicotinamide release and influencing salvage flux. Additionally, feedback inhibition by NAD+ and its metabolites fine-tunes pathway activity to maintain homeostasis.
nicotinamide metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NAMPT | Metabolic disorders, cancer, inflammation | Conditional knockout mouse, CRISPR KO in cell lines |
| NNMT | Obesity, cancer, metabolic syndrome | NNMT knockout mice, overexpression cell models |
| CD38 | Age-related NAD+ decline, immune dysfunction | CD38 knockout mice, pharmacological inhibition |
| NMNAT2 | Neurodegeneration, axonopathy | NMNAT2 knockout neurons, knock-in of patient mutations |
| SIRT1 | Aging, metabolic syndrome, cancer | SIRT1 transgenic and knockout models |
Cardiovascular disease
Cardiac NAD+ depletion, driven by dysregulated nicotinamide metabolism, promotes hypertrophic cardiomyopathy and arrhythmias in mice prior to impaired bioenergetics. This suggests that maintaining NAD+ through nicotinamide salvage could be cardioprotective.
Skin disorders
Nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, improving epidermal permeability barrier function. This supports its use in dermatological conditions characterized by barrier dysfunction.
Metabolic and inflammatory diseases
Nicotinamide riboside supplementation in aged humans augments the skeletal muscle NAD+ metabolome and induces anti-inflammatory signatures, highlighting the therapeutic potential of targeting nicotinamide metabolism in metabolic and inflammatory conditions.
Cancer
Many tumors exhibit elevated NAD+ turnover and dependence on nicotinamide salvage for survival and proliferation. Enzymes such as NAMPT and NNMT are often overexpressed in cancer, making them attractive targets for therapy.
From nicotinamide metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NAMPT affect NAD+ levels and cell survival? | CRISPR knockout of NAMPT in human cell lines |
| How do point mutations in NMNAT1 alter enzyme activity? | CRISPR point mutation knock-in of patient variants |
| Can overexpression of NRK1 enhance NAD+ salvage? | CRISPR-mediated overexpression of NRK1 in muscle cells |
| What is the effect of NNMT knockout on nicotinamide methylation? | NNMT knockout mouse model |
| Does tagged NAMPT localize differently under metabolic stress? | Knock-in of fluorescent tag at NAMPT locus |
| Which genes regulate nicotinamide metabolism in cancer? | Genome-wide CRISPR library screening |
How to Study the nicotinamide metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Nicotinamide, NAD+, NMN, 1-MNA levels | Quantifying pathway flux in cells and tissues |
| RNA-seq | Transcriptional changes in metabolic genes | Assessing response to NR supplementation |
| Western blot | Protein expression of NAMPT, NNMT, etc. | Validating CRISPR knockout or overexpression |
| Enzyme activity assay | NAMPT or NNMT catalytic activity | Functional characterization of point mutants |
| CRISPR screen | Gene essentiality or fitness linked to NAD+ metabolism | Discovery of novel regulators |
| Immunofluorescence | Subcellular localization of enzymes | Studying compartmentalized NAD+ synthesis |
| Seahorse assay | Mitochondrial respiration and glycolysis | Linking nicotinamide metabolism to bioenergetics |
| Ceramide quantification | Skin lipid levels | Evaluating nicotinamide effects on barrier function |
Metabolomics and NAD+ quantification
Mass spectrometry-based metabolomics allows direct measurement of nicotinamide, NAD+, and related metabolites in cells and tissues. This method is essential for assessing pathway flux and the impact of genetic perturbations.
Transcriptomics and RNA-seq
RNA sequencing reveals changes in gene expression across the nicotinamide metabolic network in response to interventions such as nicotinamide riboside supplementation, as shown in aged human skeletal muscle.
Proteomics and enzyme activity assays
Western blotting and activity assays for NAMPT, NNMT, and NMNATs provide functional validation of CRISPR edits. Proteomic profiling can uncover post-translational regulation of these enzymes.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate nicotinamide metabolism and NAD+ levels, offering unbiased discovery of novel regulators.
How CRISPR Can Be Used to Study GO:0006769 nicotinamide metabolic process
Knockout
CRISPR knockout of genes such as NAMPT, NNMT, or CD38 enables researchers to determine their essentiality and impact on NAD+ homeostasis. For example, NAMPT knockout in cell lines leads to rapid NAD+ depletion and cell death, confirming its role in the salvage pathway.
Point Mutation
Introducing patient-derived point mutations in genes like NMNAT1 or NADSYN1 via CRISPR allows functional assessment of enzyme activity and stability. This approach helps establish causality between specific variants and metabolic dysfunction.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous loci (e.g., NAMPT-GFP) permits real-time tracking of protein localization and interactions under physiological conditions. This is valuable for understanding compartmentalized NAD+ metabolism.
Overexpression
CRISPR activation (CRISPRa) or knock-in of strong promoters can overexpress genes like NRK1 or NMNAT3 to boost NAD+ salvage. Such models are used to test whether enhancing nicotinamide metabolism confers metabolic or stress resistance.
How EDITGENE Supports nicotinamide metabolic process Research
Researchers studying nicotinamide metabolic process-related genes often need to determine whether a candidate gene is causally involved in NAD+ regulation, metabolic disease, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for nicotinamide metabolic process research.
Frequently Asked Questions About nicotinamide metabolic process
What is nicotinamide metabolic process?
Nicotinamide metabolic process (GO:0006769) refers to the chemical reactions and pathways involving nicotinamide, a vitamin B3 vitamer and key precursor to NAD+.
What genes are involved in nicotinamide metabolic process?
Key genes include NAMPT, NMNAT1-3, NNMT, CD38, PARP1, SIRT1, NADSYN1, NAPRT, and NRK1/2.
How is nicotinamide converted to NAD+?
NAMPT converts nicotinamide to NMN, which is then adenylylated by NMNATs to form NAD+.
What is the role of nicotinamide in skin health?
Nicotinamide increases ceramide and stratum corneum lipid biosynthesis, improving epidermal barrier function.
Can nicotinamide riboside boost NAD+ in humans?
Yes, oral nicotinamide riboside is bioavailable and augments the NAD+ metabolome in aged human skeletal muscle.
How does NAD+ depletion affect the heart?
Cardiac NAD+ depletion promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics.
What diseases are linked to nicotinamide metabolism?
Cardiovascular disease, skin disorders, metabolic syndrome, inflammation, and cancer.
How can I study nicotinamide metabolic process in the lab?
Use CRISPR knockout, point mutation, or overexpression models combined with metabolomics and RNA-seq.
What is the difference between nicotinamide and nicotinamide riboside?
Nicotinamide is the amide of nicotinic acid, while nicotinamide riboside is a nucleoside form; both can be salvaged to NAD+ but via different enzymes.
Why is nicotinamide metabolism important for aging?
It maintains NAD+ levels, which decline with age and affect sirtuin activity, DNA repair, and inflammation.
Conclusion
Nicotinamide metabolic process (GO:0006769) is a central hub in NAD+ biology, influencing energy metabolism, cell survival, inflammation, and tissue-specific functions. Its dysregulation is implicated in cardiovascular disease, skin disorders, metabolic syndrome, and cancer, making it a prime target for therapeutic intervention. Advances in CRISPR gene editing and metabolomics now allow precise dissection of this pathway. By leveraging knockout, point mutation, knock-in, and overexpression models, researchers can uncover causal roles of individual genes and accelerate the development of NAD+-targeted therapies.
References
- 1. Migaud ME et al.. 2024. Regulation of and challenges in targeting NAD(+) metabolism.. Nat Rev Mol Cell Biol 25(10):822-840 PMID: 39026037
- 2. Osterman I et al.. 2024. Phages reconstitute NAD(+) to counter bacterial immunity.. Nature 634(8036):1160-1167 PMID: 39322677
- 3. Elhassan YS et al.. 2019. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.. Cell Rep 28(7):1717-1728.e6 PMID: 31412242
- 4. Trammell SA et al.. 2016. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.. Nat Commun 7:12948 PMID: 27721479
- 5. Camillo L et al.. 2025. Nicotinamide: A Multifaceted Molecule in Skin Health and Beyond.. Medicina (Kaunas) 61(2) PMID: 40005371
- 6. Dhuguru J et al.. 2023. Defining NAD(P)(H) Catabolism.. Nutrients 15(13) PMID: 37447389
- 7. Doan KV et al.. 2024. Cardiac NAD(+) depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics.. Nat Cardiovasc Res 3(10):1236-1248 PMID: 39294272
- 8. Tanno O et al.. 2000. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier.. Br J Dermatol 143(3):524-31 PMID: 10971324
